Steffen Mueller

Co-Founder, President & Chief Scientific Officer at Codagenix

Dr. Steffen Mueller is a pioneer in the field of synthetic virology and a gifted experimentalist. As a skilled, driven scientist, Dr. Mueller oversees all R&D activities at Codagenix and still works-hands on at the bench to ensure project success. He currently leads a team of 6 scientists, simultaneously managing projects involving multiple, unrelated viruses including Zika, Dengue, Influenza A, Influenza B, RSV, Yellow Fever, and PRRS viruses. He and his team have successfully generated first in class vaccine candidates against many pathogens – going from synthetically designed DNA to efficacious live vaccines. Dr. Mueller earned his BS in Biology from the University of Cologne, Germany, an MS in Genetics, Developmental Biology, Biochemistry from the University of Cologne, Germany and his Ph.D. in Molecular Microbiology from Stony Brook University.

Location

Stony Brook, United States

Links


Org chart


Teams


Offices

This person is not in any offices


Codagenix

Codagenix Inc. is a clinical stage biotechnology company with vaccine products against influenza, respiratory syncytial virus, dengue virus, and others currently under development.


Industries

Employees

11-50

Links